<DOC>
	<DOCNO>NCT00904475</DOCNO>
	<brief_summary>Patients moderate severe chronic Low Back Pain ( LBP ) despite current analgesic treatment participate Phase IV clinical trial evaluate analgesic efficacy lidocaine patch 5 % compare placebo treat moderate severe chronic LBP .</brief_summary>
	<brief_title>Pilot Study Efficacy Safety Lidoderm Patch Treatment Low Back Pain</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>1 . Were currently experience moderate/severe pain despite current analgesic treatment 2 . Had daily moderatetosevere LBP least 3 month duration 3 . Had mean daily pain intensity score &gt; 6 0 10 scale , 0 pain 10 pain bad patient ever imagine ( Question 5 BPI ) baseline week ; patient complete daily diary assessment least 5 7 day baseline week 1 . Had history great one back surgery , one back surgery within 3 month study entry 2 . Had severe spinal stenosis 3 . Had chronic back pain &gt; 12 month duration undefined spinal diagnosis 4 . Had radicular symptom radiation thigh ( i.e. , knee , calf , foot , etc . ) 5 . Had receive epidural steroid/local anesthetic injection within 2 week prior study entry 6 . Had receive trigger point injection within 2 week prior study entry 7 . Had receive Botulinum Toxin Injections LBP within 3 month prior study entry 8 . Were take lidocainecontaining product could discontinue receive study medication 9 . Were take class 1 antiarrhythmic drug ( e.g. , mexiletine , tocainide ) 10 . Had receive Lidoderm LBP past</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>